2008, Número 3
High prevalence of overweight, obesity, and biochemical risk factors for cardiovascular disease among young nurses: importance of metabolic syndrome
Méndez-Sánchez N, Montaño-Reyes MA, Chávez-Tapia NC, Sánchez-Lara K, Lezama-Mora J, Vásquez-Fernández F, Pérez-Sosa JA, Zamora-Valdés D, Uribe M
Idioma: Ingles.
Referencias bibliográficas: 22
Paginas: 185-190
Archivo PDF: 106.46 Kb.
RESUMEN
Objetivo: Actualmente existe una enorme cantidad de información sobre el síndrome metabólico, sin embargo, los estudios sobre trabajadores son escasos, especialmente los que evalúan enfermedades cardiovasculares. El objetivo del presente estudio es determinar la prevalencia de síndrome metabólico, obesidad y enfermedad cardiovascular así como su relación entre sí, en el personal de enfermería del Hospital Médica Sur.
Métodos: Se realizó un estudio transversal donde se determinaron antropometría, concentraciones sanguíneas de glucosa, insulina, perfil de lípidos, pruebas de función hepática y proteína C ultrasensible (PCRu) en el 78% (n=479) de las enfermeras de nuestro Hospital. El síndrome metabólico fue diagnosticado de acuerdo a los criterios ATP III. El riesgo de enfermedad cardiovascular fue determinado mediante los niveles de proteína C reactiva y los índices LDL/HDL y colesterol/HDL.
Resultados: Se incluyeron 370 pacientes, de los cuales 97.8% son mujeres, con una edad promedio de 30.9 años. La prevalencia de síndrome metabólico fué de 12.4%, sobrepeso (IMC ›27 m/kg
2) 34.9% y obesidad (IMC ›30 m/kg
2) de 20%. En aquellos que presentaron síndrome metabólico se observó un incremento en el riesgo de enfermedades cardiovasculares (concentraciones de PCRu ›3 mg/L). En el análisis mutivariado, se observó que la mayor probabilidad presentar síndrome metabólico se encuentra en aquellos con aumento en la relación colesterol total/HDL (OR 4.8; IC95% 2.9-7.9).
Conclusiones: La prevalencia de síndrome metabólico es similar a la reportada en la población general. Observamos una fuerte asociación entre la prevalencia de obesidad y riesgo cardiovascular. Este tipo de análisis no se ha reportado previamente en el personal de salud, por lo que instaurar programas de intervención eficientes es de primordial importancia.
REFERENCIAS (EN ESTE ARTÍCULO)
Archard C, Thiers J. Le virlisme pilaire et son association a l’insuffisance glycolytique (diabe‘te des femmes a barb). Bull Acad Natl Med 1921; 86: 51-64.
Vague J. The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease. Am J Clin Nutr 1956; 4: 20-34.
Mendez-Sanchez N, Chavez-Tapia NC, Motola-Kuba D, Sanchez-Lara K, Ponciano-Rodriguez G, Baptista H, Ramos MH, Uribe M. Metabolic syndrome as a risk factor for gallstone disease. World J Gastroenterol 2005; 11: 1653-1657.
Ford ES, Giles WH. A comparison of the prevalence of the metabolic syndrome using two proposed definitions. Diabetes Care 2003; 26: 575-581.
Aguilar-Salinas CA, Rojas R, Gomez-Perez FJ, Valles V, Rios-Torres JM, Franco A, Olaiz G, Rull JA, Sepulveda J. Analysis of the agreement between the World Health Organization criteria and the National Cholesterol Education Program-III definition of the metabolic syndrome: results from a population-based survey. Diabetes Care 2003; 26: 1635.
Ford ES. The metabolic syndrome and mortality from cardiovascular disease and all-causes: findings from the National Health and Nutrition Examination Survey II Mortality Study. Atherosclerosis 2004; 173: 309-314.
Nakanishi N, Kashiwakura Y, Nishina K, Matsuo Y, Takatorige T, Suzuki K. Metabolic syndrome and risk of isolated ST-T abnormalities and type 2 diabetes in Japanese male office workers. Ind Health 2005; 43: 269-276.
Shiwaku K, Nogi A, Kitajima K, Anuurad E, Enkhmaa B, Yamasaki M, Kim JM, Kim IS, Lee SK, Oyunsuren T, Yamane Y. Prevalence of the metabolic syndrome using the modified ATP III definitions for workers in Japan, Korea and Mongolia. J Occup Health 2005; 47: 126-135.
Hernandez-Avila M, Romieu I, Parra S, Hernandez-Avila J, Madrigal H, Willett W. Validity and reproducibility of a food frequency questionnaire to assess dietary intake of women living in Mexico City. Salud Publica Mex 1998; 40: 133-140.
Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497.
Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
Roberts WL, Moulton L, Law TC, Farrow G, Cooper-Anderson M, Savory J, Rifai N. Evaluation of nine automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Part 2. Clin Chem 2001; 47: 418-425.
Alegria E, Cordero A, Laclaustra M, Grima A, Leon M, Casasnovas JA, Luengo E, del Rio A, Ferreira I. [Prevalence of metabolic syndrome in the Spanish working population: MESYAS registry]. Rev Esp Cardiol 2005; 58: 797-806.
Kivimaki M, Lawlor DA, Juonala M, Smith GD, Elovainio M, Keltikangas-Jarvinen L, Vahtera J, Viikari JS, Raitakari OT. Lifecourse socioeconomic position, C-reactive protein, and carotid intima - media thickness in young adults: the cardiovascular risk in Young Finns Study. Arterioscler Thromb Vasc Biol 2005; 25: 2197-2202.
Regitz-Zagrosek V, Lehmkuhl E, Weickert MO. Gender differences in the metabolic syndrome and their role for cardiovascular disease. Clin Res Cardiol 2006; 95: 136-147.
Lo J, Dolan SE, Kanter JR, Hemphill LC, Connelly JM, Lees RS, Grinspoon SK. Effects of obesity, body composition, and adiponectin on carotid intima - media thickness in healthy women. J Clin Endocrinol Metab 7: Epub ahead of print, 2006.
Appel SJ, Harrell JS, Davenport ML. Central obesity, the metabolic syndrome, and plasminogen activator inhibitor-1 in young adults. J Am Acad Nurse Pract 2005; 17: 535-541.
Turhan H, Yasar AS, Basar N, Bicer A, Erbay AR, Yetkin E. High prevalence of metabolic syndrome among young women with premature coronary artery disease. Coron Artery Dis 2005; 16: 37-40.
Ferreira I, Twisk JW, van Mechelen W, Kemper HC, Stehouwer CD. Development of fatness, fitness, and lifestyle from adolescence to the age of 36 years: determinants of the metabolic syndrome in young adults: the Amsterdam Growth and Health Longitudinal Study. Arch Intern Med 2005; 165: 42-48.
Tsai CJ, Leitzmann MF, Willett WC, Giovannucci EL. Glycemic load, glycemic index, and carbohydrate intake in relation to risk of cholecystectomy in women. Gastroenterology 2005; 129: 105-112.
Mikurube H, Kaneko M, Murata C, Komaki Y, Ishikawa N, Higashiyama R, Fukasawa K, Watanabe T. Association of change in the type of job with prevalence of components of the metabolic syndrome-special reference to job stress. Nippon Koshu Eisei Zasshi 2005; 52: 987-993.